Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release

References

• Brady SF, Wagenaar MM, Singh MP, et al. (2000). The cytosporones, new octaketide antibiotics isolated from an endophytic fungus. Org Lett 2:4043–6
   PubMed Web of Science ®Google Scholar
• Cho SD, Yoon K, Chintharlapalli S, et al. (2007). Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor–dependent and nuclear receptor–independent pathways. Cancer Res 67:674–83
   PubMed Web of Science ®Google Scholar
• Dai WT, Zhang DR, Duan CX, et al. (2010). Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system. J Microencapsul 27:234–41
   PubMed Web of Science ®Google Scholar
• Doktorovová S, Araújo J, Garcia ML, et al. (2010). Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC). Colloids Surf B Biointerfaces 75:538–42
   PubMed Web of Science ®Google Scholar
• Giguère V. (1999). Orphan nuclear receptors: from gene to function. Endocr Rev 20:689–725
   PubMed Web of Science ®Google Scholar
• Hao LL, Wang XY, Zhang DR, et al. (2012). Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals. Int J Pharm 433:157–64
   PubMed Web of Science ®Google Scholar
• Hu FQ, Jiang SP, Du YZ, et al. (2006). Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm 314:83–9
   PubMed Web of Science ®Google Scholar
• Hu FQ, Yuan H, Zhang HH, Fang M. (2002). Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm 239:121–8
   PubMed Web of Science ®Google Scholar
• Hu FQ, Zhang Y, Du YZ, Yuan H. (2008). Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system. Int J Pharm. 348:146–52
   PubMed Web of Science ®Google Scholar
• Jenning V, Thünemann AF, Gohla SH. (2000). Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199:167–77
   PubMed Web of Science ®Google Scholar
• Jia LJ, Shen JY, Zhang DR, et al. (2012). In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol 50:523–9
   PubMed Web of Science ®Google Scholar
• Jia LJ, Zhang DR, Li ZY, et al. (2010a). Preparation and characterization of silybin-loaded nanostructured lipid carriers. Drug Deliv 17:11–18
   PubMed Web of Science ®Google Scholar
• Jia LJ, Zhang DD, Li ZY, et al. (2010b). Nanostructured lipid carriers for parenteral delivery of silybin: biodistribution and pharmacokinetic studies. Colloids Surf B Biointerfaces 80:213–18
   PubMed Web of Science ®Google Scholar
• Kolluri SK, Bruey-Sedano N, Cao X, et al. (2003). Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol Cell Biol 23:8651–67
   PubMed Web of Science ®Google Scholar
• Li Q, Ke N, Sundaram R, Wong-Staal F. (2006). NR4A1, 2, 3 an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol Histopathol 21:533–40
   PubMed Web of Science ®Google Scholar
• Lin XH, Li XW, Zheng LQ, et al. (2007). Preparation and characterization of monocaprate nanostructured lipid carriers. Colloid Surface A 311:106–11
   Web of Science ®Google Scholar
• Liu JJ, Zeng HN, Zhang LR, et al. (2010). A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro. Cancer Res 70:3628–37
   PubMed Web of Science ®Google Scholar
• Maruyama K, Tsukada T, Ohkura N, et al. (1998). The NGFI-B subfamily of the nuclear receptor superfamily (review). Int J Oncol 12:1237–43
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mäder K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 47:165–96
   PubMed Web of Science ®Google Scholar
• Müller R, Jacobs C. (2002). Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. Int J Pharm 237:151–61
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur J Pharm Biopharm 50:161–77
   PubMed Web of Science ®Google Scholar
• Müller R, Radtke M, Wissing S. (2002a). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–8
   PubMed Web of Science ®Google Scholar
• Müller R, Radtke M, Wissing S. (2002b). Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54:S131–55
   PubMed Web of Science ®Google Scholar
• Sibayama-Imazu T, Fujisawa Y, Masuda Y, et al. (2008). Induction of apoptosis in PA-1 ovarian cancer cells by vitamin K2 is associated with an increase in the level of TR3/Nur77 and its accumulation in mitochondria and nuclei. J Cancer Res Clin 134:803–12
   PubMed Web of Science ®Google Scholar
• Wu Q, Liu S, Ye XF, et al. (2002). Dual roles of Nur77 in selective regulation of apoptosis and cell cycle by TPA and ATRA in gastric cancer cells. Carcinogenesis 23:1583–92
   PubMed Web of Science ®Google Scholar
• Zhai YJ, Guo SS, Liu CH, et al. (2013). Preparation and in vitro evaluation of apigenin-loaded polymeric micelles. Colloid Surface A 429:24–30
   Web of Science ®Google Scholar
• Zhan YY, Du XP, Chen HZ, et al. (2008). Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat Chem Biol 4:548–56
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhao YL, Geng LL, et al. (2011). Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography–mass spectrometry: Evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier. J Chromatogr B 879:3721–7
   PubMed Web of Science ®Google Scholar
• Zur Mühlen A, Zur Mühlen E, Niehus H, Mehnert W. (1996). Atomic force microscopy studies of solid lipid nanoparticles. Pharmaceut Res 13:1411–16
   PubMed Web of Science ®Google Scholar